Nowak, H.; Vornweg, S.; Rump, K.; Rahmel, T.; Unterberg, M.; Koos, B.; Schenker, P.; Viebahn, R.; Adamzik, M.; Bergmann, L.
The NFKB1 Promoter Polymorphism (-94ins/delATTG) Is Associated with Susceptibility to Cytomegalovirus Infection after Kidney Transplantation and Should Have Implications on CMV Prophylaxis Regimens. Cells 2021, 10, 380.
https://doi.org/10.3390/cells10020380
AMA Style
Nowak H, Vornweg S, Rump K, Rahmel T, Unterberg M, Koos B, Schenker P, Viebahn R, Adamzik M, Bergmann L.
The NFKB1 Promoter Polymorphism (-94ins/delATTG) Is Associated with Susceptibility to Cytomegalovirus Infection after Kidney Transplantation and Should Have Implications on CMV Prophylaxis Regimens. Cells. 2021; 10(2):380.
https://doi.org/10.3390/cells10020380
Chicago/Turabian Style
Nowak, Hartmuth, Svenja Vornweg, Katharina Rump, Tim Rahmel, Matthias Unterberg, Björn Koos, Peter Schenker, Richard Viebahn, Michael Adamzik, and Lars Bergmann.
2021. "The NFKB1 Promoter Polymorphism (-94ins/delATTG) Is Associated with Susceptibility to Cytomegalovirus Infection after Kidney Transplantation and Should Have Implications on CMV Prophylaxis Regimens" Cells 10, no. 2: 380.
https://doi.org/10.3390/cells10020380
APA Style
Nowak, H., Vornweg, S., Rump, K., Rahmel, T., Unterberg, M., Koos, B., Schenker, P., Viebahn, R., Adamzik, M., & Bergmann, L.
(2021). The NFKB1 Promoter Polymorphism (-94ins/delATTG) Is Associated with Susceptibility to Cytomegalovirus Infection after Kidney Transplantation and Should Have Implications on CMV Prophylaxis Regimens. Cells, 10(2), 380.
https://doi.org/10.3390/cells10020380
